Pharmaceutical firms announce they have plans in place to adapt their COVID-19 vaccines if necessary after Omicron cases emerge in some countries
With the emergence of the Omicron COVID-19 variant, which has now been detected in southern Africa, Europe, Israel and Hong Kong,